A PHASE 3, RANDOMIZED, PARALLEL, MULTICENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO INVESTIGATE EFFICACY AND SAFETY OF KP-001 IN PATIENTS AGED =/> 2 YEARS WITH COMMON VENOUS MALFORMATIONS, COMMON LYMPHATIC MALFORMATIONS, OR KTS/CLOVES SYNDROME

Registry ID

KP-001-303

Source registry

HEALTH_CANADA

Status

Pending

Phase

PHASE3

Study type

INTERVENTIONAL

Sponsor

KAKEN PHARMACEUTICAL CO., LTD.

Last update

2026-01-14

Conditions

• VASCULAR MALFORMATION

View on source registry